Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01639508 |
|---|---|
| Brief Title: | Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity |
| First Submitted : | July 10, 2012 |
| First Submitted that Met QC Criteria : | July 11, 2012 |
| First Posted : | July 12, 2012 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 23, 2023 |
| Last Update Posted : | June 26, 2023 |